Does zero balance ultrafiltration decrease the incidence of post-cardiopulmonary bypass atrial fibrillation?

Journal of Extra-Corporeal Technology

Volumn 40, Issue 2, 2008, Pages 109-115

  Lucas, Mark T ^a,c   Limoli, John ^a   Schlut, Joseph ^a   Holt, David W ^b  

^a St Anthony Central Hospital   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c Denver Cardiovascular Perfusionists   (United States)

Author keywords

Atrial fibrillation; Coronary bypass; Hemofiltration; Inflammation; Zero balance ultrafiltration

Indexed keywords

ANTIFIBRINOLYTIC AGENT;

ADULT; AGE DISTRIBUTION; ARTICLE; ASSISTED VENTILATION; BLOOD; BLOOD TRANSFUSION; CARDIOPULMONARY BYPASS; COMORBIDITY; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; FEMALE; HEART ATRIUM FIBRILLATION; HEART HEMODYNAMICS; HEART SURGERY; HOSPITALIZATION; HUMAN; INCIDENCE; INFLAMMATION; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE COMPLICATION; RETROSPECTIVE STUDY; SEX DIFFERENCE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; THERAPY; ZERO BALANCE ULTRAFILTRATION; AGE; AGED; HEMOFILTRATION; MIDDLE AGED; RISK; RISK FACTOR;

AGE FACTORS; AGED; ATRIAL FIBRILLATION; CARDIOPULMONARY BYPASS; CORONARY ARTERY BYPASS; FEMALE; HEMOFILTRATION; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS;

EID: 54449083931     PISSN: 00221058     EISSN: 29698960     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Aranki SF, Shaw DP, Adams DH, et al. Predictors of atrial fibrillation after coronary artery surgery current trends and impact on hospital resources. Circulation. 1996;94:390-7.
2. Mathew JP, Parks R, Savino JS, et al. Atrial fibrillation following coronary bypass artery graft surgery: predictors, outcomes, and resource utilization. JAMA. 1996;276:300-6.
3. Hogue CW, Creswell LL, Gutterman DD, Fleisher LA. Epidemiology, mechanisms, and risks.* American College of Chest Physicians Guidelines for the Prevention and Management of Postoperative Atrial Fibrillation After Cardiac Surgery. Chest. 2005;128:9S-16S.
4. Thom T, Haase N, Rosamond W, et al. Heart disease and stroke statistics - 2006 update. A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2006;113:e696.
5. Kowey PR, Stebbins D, Igidbashian L, et al. Clinical outcome of patients who develop PAF after CABG surgery. Pacing Clin Electrophysiol. 2001;24:191-3.
6. Steinberg JS. Postoperative atrial fibrillation: a billion-dollar problem. J Am Coll Cardiol. 2004;43:1001-3.
7. Funk M, Richards SB, Desjardins J, et al. Incidence, timing, symptoms, and risk factors for atrial fibrillation after cardiac surgery. Crit Care. 2003;12:424-35.
8. Mariscalco G, Engstrom KG, Ferratese S, et al. Relationship between atrial histopathology and atrial fibrillation after coronary bypass surgery. J Thorac Cardiovasc Surg. 2006;131:1364-72.
9. Bruins P, te Velthuis H, Yazdanbakhsh AP, et al. Activation of the complement system during and after cardiopulmonary bypass surgery postsurgery activation involves C-reactive protein and is associated with postoperative arrhythmia. Circulation. 1997;96:3542-8.
10. Frustaci A, Chimenti C, Bellocci F, Morgante E, Russo MA, Maseri A. Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation. 1997;96:1180-4.
11. Aviles RJ, Martin DO, Apperson-Hansen C, et al. Inflammation as a risk factor for atrial fibrillation. Circulation. 2003;108:3006-10.
12. Engelmann MD, Svendsen JH. Inflammation in the genesis and perpetuation of atrial fibrillation. Eur Heart J. 2005;26:2083-92.
13. Ishii Y, Schuessler RB, Gaynor SL, et al. Inflammation of atrium after cardiac surgery is associated with inhomogeneity of atrial conduction and atrial fibrillation. Circulation. 2005;111:2881-8.
14. Chung MK, Martin DO, Sprecher D, et al. C-reactive protein elevation in patients with atrial arrhythmias. Inflammatory mechanisms and persistence of atrial fibrillation. Circulation. 2001;104:2886-91.
15. Baufreton C, Allain P, Chevallier A, et al. Brain injury and neuropsychological outcome after coronary artery surgery are affected by complement activation. Ann Thorac Surg. 2005;79:1597-605.
16. Levy JH, Tanaka KA. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg. 2003;75:S715-20.
17. Rubens FD, Mesana T. The inflammatory response to cardiopulmonary bypass: a therapeutic overview. Perfusion. 2004;19(Suppl 1):S5-12.
18. Wan S, LeClerc JL, Vincent JL. Inflammatory response to cardiopulmonary bypass: mechanisms involved and possible therapeutic strategies. Chest. 1997;112:676-92.
19. Nieman GF, Seales B, Carney D, et al. Systemic inflammation induced by cardiopulmonary bypass: a review of pathogenesis and treatment. J Extra Corpor Technol. 1999;31:202-10.
20. Holmes JH 4th, Connolly NC, Pauli DL, et al. Magnitude of the inflammatory response to cardiopulmonary bypass and its relation to adverse clinical outcomes. Inflamm Res. 2002;51:579-86.
21. Creswell LL, Alexander JC Jr, Ferguson TB Jr, Lisbon A, Fleisher LA. Intraoperative interventions: American College of Chest Physicians Guidelines for the Prevention and Management of Postoperative Atrial Fibrillation After Cardiac Surgery. Chest. 2005;128:28S-35S.
22. Crystal E, Connolly SJ, Sleik K, Ginger TJ, Yusuf S, Phil D. Interventions on prevention of postoperative atrial fibrillation in patients undergoing heart surgery: a meta-analysis. Circulation. 2002;106:75-80.
23. Hilleman DE, Hunter CE, Mohiuddin SM, Maciejewski S. Pharmacological management of atrial fibrillation following cardiac surgery. Am J Cardiovasc Drugs. 2005;5:361-9.
24. Olivencia-Yurvati AH, Wallace WE, Wallace N, et al. Intraoperative treatment strategy to reduce the incidence of post cardiopulmonary bypass atrial fibrillation. Perfusion. 2002;17(Suppl):35-9.
25. Olivencia-Yurvati AH, Wallace N, Ford S, Mallet RT. Leukocyte filtration and aprotinin: synergistic anti-inflammatory protection. Perfusion. 2004;19(Suppl 1):S13-9.
26. Turkoz A, Cigli A, But K, et al. The effects of aprotinin and steroids on generation of cytokines during coronary artery surgery. J Cardiothorac Vasc Anesth. 2001;15:603-10.
27. Gott JP, Cooper WA, Schmidt FE, et al. Modifying risk for extracorporeal circulation: trial of four anti-inflammatory strategies. Ann Thorac Surg. 1998;66:747-54.
28. Journois D, Israel-Biet D, Pouard P, et al. High-volume, zero-balanced hemofiltration to reduce delayed inflammatory response to cardiopulmonary bypass in children. Anesthesiology. 1996;85:965-76.
29. Tallman RD, Dumond M, Brown D. Inflammatory mediator removal by zero-balance ultrafiltration during cardiopulmonary bypass. Perfusion. 2002;17:111-5.
30. Berdat PA, Eichenberger E, Ebell J, et al. Elimination of proinflammatory cytokines in pediatric cardiac surgery: analysis of ultrafiltration method and filter type. J Thorac Cardiovasc Surg. 2004;127: 1688-96.
31. Zhu M, Wang W, Hong C, Zhang W, Ding X. Balanced ultrafiltration, modified ultrafiltration, and balanced ultrafiltration with modified ultrafiltration in pediatric cardiopulmonary bypass. J Extra Corpor Technol. 2001;33:223-6.
32. Millar AB, Armstrong L, van der Linden J, et al. Cytokine production and hemofiltration in children undergoing cardiopulmonary bypass. Ann Thorac Surg. 1993;56:1499-502.
33. Clar A, Bowers MC, Larson DF. Derivation of sieving coefficients to determine the efficacy of the hemoconcentrator in removal of four inflammatory mediators produced during cardiopulmonary bypass. ASAIO J. 1997;43:163-70.
34. Darling E, Searles B, Nasrallah F, et al. High-volume, zero balanced ultrafiltration improves pulmonary function in a model of post-pump syndrome. J Extra Corpor Technol. 2002;34:254-9.
35. Huang H, Yao T, Wang W, et al. Continuous ultrafiltration attenuates the pulmonary injury that follows open heart surgery with cardiopulmonary bypass. Ann Thorac Surg. 2003;76:136-40.
36. Acione R, Caputo M, Calori G, Lloyd CT, Underwood MJ, Angelini GD. Predictors of atrial fibrillation after conventional and beating heart coronary surgery. Circulation. 2000;102:1530-35.
37. Gaudino M, Andreotti F, Zamparelli R, et al. The -174G/C interleukin-6 polymorphism influences postoperative interleukin-6 levels and postoperative atrial fibrillation. Is atrial fibrillation an inflammatory complication? Circulation. 2003;108:195-9.
38. Cummings JE, Gill I, Akhrass R, Dery MA, Biblo LA, Quan KJ. Preservation of the anterior fat pad paradoxically decreases the incidence of postoperative atrial fibrillation in humans. J Am Coll Cardiol. 2004;43:994-1000.
39. Švagždiené M, Širvinskas E. Changes in serum electrolyte levels and their influence on the incidence of atrial fibrillation after coronary artery bypass grafting surgery. Medicina (Kaunas). 2006;42:208-14.
40. Koch CG, Li L, Van Wagoner DR, Duncan AI, Gillinov AM, Blacksonte EH. Red cell transfusion is associated with an increased risk for postoperative atrial fibrillation. Ann Thorac Surg. 2006;82:1747-57.
41. Fontes M, Mathew J, Rinder HM, Zelterman D, Smith BR, Rinder CS, and the Multicenter Study of Perioperative Ischemia Group. Atrial fibrillation after cardiac surgery/cardiopulmonary bypass is associated with monocyte activation. Anesth Analg. 2005;101:17-23.
42. Goette A, Arndt M, Röcken C, et al. Calpains and cytokines in fibrillating human atria. Am J Physiol Heart Circ Physiol. 2002;283: 264-72.
43. Mukamal KJ, Tolstrup JS, Friberg J, Gronbaek M, Jensen G. Fibrinogen and albumin levels and risk of atrial fibrillation in men and women (the Copenhagen City Heart Study). Am J Cardiol. 2006;98: 75-81.
44. Fitzgerald DJ, Cecere G. Hemofiltration and inflammatory mediators. Perfusion. 2002;17(Suppl):23-8.
45. Van Norman GA, Patel MA, Chandler W, Vocelka C. Effects of hemofiltration on serum aprotinin levels in patients undergoing cardiopulmonary bypass. J Cardiothorac Vasc Anesth. 2000;14:253-6.
46. Bayer Pharmaceuticals. Trasylol (Aprotinin Injection) Package Insert. West Haven, CT: Bayer Pharmaceuticals; 2003.